adenosine receptor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 21, 2010
Grant Date -
May 29, 2008
app pub date -
Nov 12, 2007
filing date -
Nov 13, 2006
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention provides compounds of formula (I)adenosine receptor. Accordingly, the compounds of formula (I) may be employed for treatment of pain, in particular, chronic pain such as neuropathic pain; cardiac disease or disorder such as cardiac disarrhythmias, e.g., peroxysmal supraventricular tachycardia, angina, myocardial infarction and stroke; neurological disease or injury; sleep disorder; epilepsy; and depression.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully